Skip to main content
Clinical Trials/NCT04305262
NCT04305262
Withdrawn
N/A

Continuous Monitoring of Vital Parameters for Early Detection of Clinical Deterioration in Hospitalized Patients - a Part of the Wireless Assessment of Respiratory and Circulatory Distress (WARD) Project

University Hospital Bispebjerg and Frederiksberg0 sitesMarch 25, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Continuous Wireless Vital Parameter Monitoring
Sponsor
University Hospital Bispebjerg and Frederiksberg
Primary Endpoint
Serious desaturation
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

For patients admitted to the medical ward, it is often difficult to predict if their clinical condition will deteriorate, however subtle changes in vital signs are usually present 8 to 24 hours before a life-threatening event such as respiratory failure leading to ICU admission, or unanticipated cardiac arrest. Such adverse trends in clinical observations can be missed, misinterpreted or not appreciated as urgent. New continuous and wearable 24/7 clinical vital parameter monitoring systems offer a unique possibility to identify clinical deterioration before patients condition progress beyond the point-of-no-return, where adverse events are inevitable. The WARD project aims to determine the correlation between cardiopulmonary micro events and clinical adverse events during the first four days after hospital admission.

Registry
clinicaltrials.gov
Start Date
March 25, 2020
End Date
December 31, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital Bispebjerg and Frederiksberg
Responsible Party
Principal Investigator
Principal Investigator

Katja Kjær Grønbæk

MD, PhD-student

University Hospital Bispebjerg and Frederiksberg

Eligibility Criteria

Inclusion Criteria

  • Adults \>18 years
  • Acute hospitalization or discharge from Intensive Care Unit (ICU) after an admission of at least 24 hours.
  • Early Warning Score (EWS) ≥4 at least once from admission and until inclusion
  • One of the following tentative diagnoses as the primary reason for admission: Pneumonia, Dyspnea, Acute myocardial infarction, heartfailure or sepsis
  • Inclusion conversation possible within 12 hours of admission or discharge from ICU

Exclusion Criteria

  • Patients that cannot cooperate
  • Patients that cannot give informed consent
  • Patients with EWS≥4 that is not of presumed physical origin
  • Patients with allergies to plaster or silicone
  • Patients with pacemaker or ICD
  • Patients with treatment limitations (no resuscitation or no admission to ICU)
  • Patients with expected discharge within 24 hours
  • Patients that have been included in the WARD-COPD study (H-18026653)

Outcomes

Primary Outcomes

Serious desaturation

Time Frame: more than 10 minutes, within the first four days of acute admission

SpO2 \<85% in 10 consecutive minutes

Secondary Outcomes

  • tachycardia(one minute within the first four days of admission)
  • bradycardia(one minute within the first four days of admission)
  • tachypnea(one minute within the first four days of admission)
  • desaturation(more than 60 minutes, within the first four days of acute admission)
  • bradypnea(one minute within the first four days of admission)
  • hypotension(one measurement within the first four days of admission)
  • hypertension(one measurement wihtin the first four days of admission)

Similar Trials